219 Meta-analysis female sex and mortality in SAB 10 Table 1 (next page). Description of studies included in systematic review. Number of studies (%) N= 89 Publication year 2000-2010 2011-2023 21 (24) 68 (76) Study design Cohort study Post-hoc analysis randomized trial 88 (99) 1 (1) Continent Europe Asia North America Oceania South America Africa Multiple 36 (40) 24 (27) 20 (22) 5 (6) 1 (1) 1 (1) 2 (2) Number of hospitals included 1 2-20 >20 44 (49) 33 (37) 13 (15) Number of patients included 200 – 1,000 1,000 – 10,000 >10,000 69 (78) 15 (17) 4 (4) Population All SAB patients Healthcare/hospital-associated SAB Community-acquired SAB 82 (92) 3 (3) 4 (4) Outcome measure 7 day mortality 14 day mortality 28-30 day mortality 90 day mortality In-hospital mortality Attributable mortality 1 (1) 4 (4) 54 (61) 9 (10) 16 (18) 5 (6) MRSA vs MSSA Both MRSA and MSSA Only MRSA Only MSSA 59 (66) 20 (22) 10 (11)
RkJQdWJsaXNoZXIy MTk4NDMw